BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19490063)

  • 21. Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al.
    Sandoo A; Toms T; Zanten JV; Carroll D; Kitas G
    Arthritis Rheum; 2009 Jun; 61(6):854-5; author reply 855-6. PubMed ID: 19479694
    [No Abstract]   [Full Text] [Related]  

  • 22. Does treatment with glucocorticoids or with disease-modifying antirheumatic drugs reduce the rate of radiographic progression in rheumatoid arthritis? Comment on the article by Abu-Shakra et al.
    Kirwan JR
    Arthritis Rheum; 1999 May; 42(5):1066-7. PubMed ID: 10323469
    [No Abstract]   [Full Text] [Related]  

  • 23. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
    Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
    Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dose glucocorticoid therapy in rheumatoid arthritis (RA): transitional or selected add-on therapy?
    Masi AT
    J Rheumatol; 1983 Oct; 10(5):675-8. PubMed ID: 6227745
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of glucocorticoids in rheumatoid arthritis--no 'rational' approach yet.
    Desai SP; Solomon DH
    Arthritis Res Ther; 2010; 12(3):127. PubMed ID: 20602811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol and chloroquine.
    Borba EF
    Rev Bras Reumatol; 2011 Dec; 51(6):673. PubMed ID: 22124601
    [No Abstract]   [Full Text] [Related]  

  • 27. Add-on or step-up trials in rheumatoid arthritis: comment on the article by Boers.
    Pincus T
    Arthritis Rheum; 2004 Apr; 50(4):1351; author reply 1351-2. PubMed ID: 15077322
    [No Abstract]   [Full Text] [Related]  

  • 28. On publication policy, combination therapy, and the European League Against Rheumatism recommendations for the management of rheumatoid arthritis: comment on the article by Graudal et al.
    Landewé R; Gorter S; Gaujoux-Viala C; Gossec L; Smolen JS
    Arthritis Rheum; 2011 Oct; 63(10):3182-4; discussion 3184-6. PubMed ID: 21702017
    [No Abstract]   [Full Text] [Related]  

  • 29. [Conception of direct participation of intestine in pathogenesis of rheumatoid arthritis].
    Frizen BN
    Ter Arkh; 1998; 70(5):24-8. PubMed ID: 9644737
    [No Abstract]   [Full Text] [Related]  

  • 30. Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
    Porter D
    Ann Rheum Dis; 2008 Sep; 67(9):1356. PubMed ID: 18697785
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment on: Multicentre survey of rheumatoid arthritis patients from Ministry of Health rheumatology centres in Malaysia.
    Yeap SS
    Int J Rheum Dis; 2009 Jul; 12(2):177-8; author reply 179. PubMed ID: 20374340
    [No Abstract]   [Full Text] [Related]  

  • 32. The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: comment on the editorial by Harris.
    Jacobs JW; Boers M; Kirwan JR; Bijlsma JW
    Arthritis Rheum; 2006 Jun; 54(6):2031-2; author reply 2032. PubMed ID: 16732571
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rheumatoid arthritis].
    Wahle M
    Dtsch Med Wochenschr; 2009 Sep; 134(36):1745-54. PubMed ID: 19718596
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cutaneous Bipolaris spicifera infection in a patient on systemic corticosteroids].
    Dubois M; Brisou P; Fournier B; Guennoc B; Carsuzaa F
    Ann Dermatol Venereol; 2008; 135(6-7):507-8. PubMed ID: 18598805
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimizing therapeutics: the next front in the war on rheumatoid arthritis.
    Edison JD; Gilliland WR
    Clin Pharmacol Ther; 2012 Apr; 91(4):561-6. PubMed ID: 22434026
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term therapy with low dosage corticoids in rheumatology is well established].
    Hatz HJ
    MMW Fortschr Med; 1999 Sep; 141(38):58-9. PubMed ID: 10904623
    [No Abstract]   [Full Text] [Related]  

  • 37. How can we improve adherence to therapy by patients with rheumatoid arthritis?
    van den Bemt BJ; van Lankveld WG
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):681. PubMed ID: 18037928
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
    Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
    J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Achievement in therapy for rheumatoid arthritis without dysfunctional sequela].
    Takeuchi T
    Clin Calcium; 2012 Feb; 22(2):167. PubMed ID: 22737767
    [No Abstract]   [Full Text] [Related]  

  • 40. Improving pregnancy counseling for women with rheumatoid arthritis taking methotrexate.
    Neeman N; Aronson MD; Schulze JE; Shmerling RH
    Am J Med; 2009 Nov; 122(11):998-1000. PubMed ID: 19854323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.